021-51111890
购物车（）
sales@molnova.cn
Mycophenolic acid-β-D-glucuronide solution
CAS No. 31528-44-6
Mycophenolic acid-β-D-glucuronide solution ( —— )
产品货号. M28548 CAS No. 31528-44-6
麦考酚酸葡萄糖醛酸是人血浆中麦考酚酸的葡萄糖醛酸代谢产物。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 5MG | ￥2341 | 有现货 |
|
| 10MG | ￥3499 | 有现货 |
|
| 25MG | ￥5792 | 有现货 |
|
| 50MG | ￥7995 | 有现货 |
|
| 100MG | 获取报价 | 有现货 |
|
| 200MG | 获取报价 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称Mycophenolic acid-β-D-glucuronide solution
-
注意事项本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断
-
产品简述麦考酚酸葡萄糖醛酸是人血浆中麦考酚酸的葡萄糖醛酸代谢产物。
-
产品描述Mycophenolic acid glucuronide is the glucuronide metabolite of mycophenolic acid in human plasma.
-
体外实验Mycophenolic acid glucuronide shows weak IMP dehydrogenase (IMPDH) type II inhibition with an IC50 of 3.3 mg/L.
-
体内实验Mycophenolic acid glucuronide (intraperitoneal injection; 6 mg/mouse; once two days; 6 d) treatment reduces tumor growth in an Ehrlich murine spontaneous adenocarcinoma model. Animal Model:Swiss albino strain mouse implanted with Ehrlich ascites tumor cells Dosage:6 mg/mouse Administration:Intraperitoneal injection; 6 mg/mouse; once two days; 6 d Result:Showed 76.8% tumor inhibition compared to the untreated control.
-
同义词——
-
通路Others
-
靶点Other Targets
-
受体——
-
研究领域——
-
适应症——
化学信息
-
CAS Number31528-44-6
-
分子量496.465
-
分子式C23H28O12
-
纯度>98% (HPLC)
-
溶解度In Vitro:?DMSO : 33.33 mg/mL (67.14 mM)
-
SMILESCOc1c(C)c2COC(=O)c2c(O[C@@H]2OC([C@@H](O)C(O)[C@@H]2O)C(O)=O)c1C\C=C(/C)CCC(O)=O
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Yasumasa KUWAHARA, et al. Flight Time of Bombyx mandarina Males to a Pheromone Trap Baited with Bombykol. J-STAGE home/Applied Entomology and Zoology/Volume 19 (1984) Issue 3.
产品手册
关联产品
-
Argipressin
Argipressin 是一种具有血管收缩和抗利尿活性的肽激素，可与血管精氨酸加压素受体 V1 结合，在 A7r5 大鼠主动脉平滑肌细胞和新生大鼠心肌细胞中的 Kd 值分别为 1.31 和 1.44 nM。
-
CHR-6494 TFA
CHR-6494 TFA 是一种有效的 haspin 抑制剂，IC50 为 2 nM。它抑制组蛋白 H3T3 磷酸化。 CHR-6494 TFA 诱导癌细胞凋亡，包括黑色素瘤和乳腺癌。 CHR-6494 TFA可用于癌症研究。
-
(-)-Epiafzelechin
(-)-Epiafzelechin exhibits significant anti-inflammatory activity on carrageenin-induced mouse paw edema, it exhibits a dose-dependent inhibition on the COX activity with an IC50 value of 15 microM, it exhibits about 3-fold weaker inhibitory potency on the enzyme activity than indomethacin as a positive control.
